- Euromonitor International
-
-
Store
WHAT'S NEWIntroducing enhanced country reports featuring interactive datagraphics, charts and analysis.Learn More
- Countries
- Industries
- Companies
- Economies
- Consumers
- Australia
- Brazil
- Canada
- China
- Colombia
- Denmark
- Egypt
- France
- Germany
- Hong Kong
- India
- Indonesia
- Ireland
- Italy
- Japan
- Kenya
- Malaysia
- Mexico
- Netherlands
- Nigeria
- Pakistan
- Peru
- Philippines
- Poland
- Romania
- Russia
- Saudi Arabia
- Singapore
- South Africa
- South Korea
- Spain
- Switzerland
- Taiwan
- Thailand
- Turkey
- United Arab Emirates
- United Kingdom
- United States
- Vietnam
- Alcoholic Drinks
- Apparel and Footwear
- Beauty and Personal Care
- Consumer Appliances
- Consumer Electronics
- Consumer Finance
- Consumer Foodservice
- Consumer Health
- Eyewear
- Fresh Food
- Health and Wellness
- Home and Garden
- Home Care
- Hot Drinks
- Industrial/Commercial
- Ingredients
- Luxury Goods
- Mobility
- Nutrition
- Packaged Food
- Packaging
- Personal Accessories
- Pet Care
- Retailing
- Soft Drinks
- Sports
- Tissue and Hygiene
- Tobacco
- Toys and Games
- Travel
- American Express Co
- Amway Corp
- Apple Inc
- Asahi Group Holdings Ltd
- Avon Products Inc
- Beiersdorf AG
- Bristol-Myers Squibb Co
- Campari Milano SpA, Davide
- Coach Inc
- Coca-Cola Co, The
- Colgate-Palmolive Co
- Danone, Groupe
- Gap Inc, The
- H&M Hennes and Mauritz AB
- Henkel AG & Co KGaA
- Herbalife Ltd
- Inditex, Industria de Diseño Textil SA
- Inter Ikea Systems BV
- Johnson & Johnson Inc
- Kao Corp
- Kraft Foods Inc
- LG Corp
- LVMH Moët Hennessy Louis Vuitton SA
- Mars Inc
- Mondelez International Inc
- Natura Cosméticos SA
- Nestlé SA
- Nu Skin Enterprises Inc
- PepsiCo Inc
- Procter & Gamble Co, The
- Reckitt Benckiser Group Plc (RB)
- Royal FrieslandCampina NV
- Samsung Corp
- Sara Lee Corp
- Seven & I Holdings Co Ltd
- Sharp Corp
- Sony Corp
- Toyo Seikan Group Holdings, Ltd
- Unilever Group
Megatrends
The most influential Megatrends set to shape the world through 2030, identified by Euromonitor International, help businesses better anticipate market developments and lead change for their industries.
Learn more
Euromonitor addresses your unique questions and challenges across all B2B and B2C industries and geographies through custom, tailor-made research projects, designed to your specific goals.
Learn more - Solutions
- Capabilities
- Blog
- Careers
- About Us
-
Store
Company Profile
GlaxoSmithKline Plc in Consumer Health
Apr 2017
US$570Added to Cart
New Report Guarantee
If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extract FREE!
About This Report
New Report Guarantee
If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extract FREE!
Since 2015, GlaxoSmithKline (GSK) has settled in as the global leader in consumer health thanks to its joint venture with Novartis that helped the company to strengthen its OTC portfolio, through key brands such as Voltaren, and expand its presence in Western Europe and China. While regulatory changes and increasing competition are risks to future performance, GSK has taken steps to continue recent success through category expansion, new brand extensions and the Rx-to-OTC switch of Flonase.
Files are delivered directly into your account within a few minutes of purchase.
Samples
Overview
Why buy this report?
Gain competitive intelligence about market leaders. Track key industry trends, opportunities and threats. Inform your marketing, brand, strategy and market development, sales and supply functions.
Euromonitor International's report on GlaxoSmithKline Plc delivers a detailed strategic analysis of the company's business, examining its performance in the Consumer Health market and the global economy.
Company and market share data provide a detailed look at the financial position of GlaxoSmithKline Plc, while in-depth qualitative analysis will help you understand the brand strategy and growth prospects of GlaxoSmithKline Plc.
This report examines:
- Company share by region and sector
- Brand portfolio
- New product developments
- Marketing and distribution strategies
A detailed SWOT analysis of GlaxoSmithKline Plc provides strategic intelligence on:
- Strengths and weaknesses
- Category and country opportunities for growth
- Challenges and threats from current competition and future prospects
- Global and regional market positions
Research You Can Trust:
Euromonitor International's company profile reports are written by our Consumer Health research team, a dedicated group of analysts that knows the industry inside and out.
Buy this report to inform your planning, strategy, marketing, sales and competitor intelligence functions.
Delivery format
Reports are delivered in PDF format and can be downloaded from your online account immediately after purchase.
Want to find out more about this report?
Request more informationTable of Contents
Introduction
Scope
Strategic Evaluation
Key company facts
GlaxoSmithKline across consumer goods
GSK main categories within consumer health
GSK becomes consumer h ealth leader after Novartis deal…
…but does not lead in prevention
SWOT: GlaxoSmithKline
Competitive Positioning
GSK growth relative to the industry
GSK returns to top spot after joint venture with Novartis
GSK development in key consumer health categories
GSK in global consumer health
Market Assessment
GSK in consumer health, major markets and CH categories
Analgesics: GSK becomes top player after Novartis deal
CCA: Leadership without brand-specific dominance
Digestive remedies: Third largest category for GSK
Geographic and Category Opportunities
GlaxoSmithKline’s regional presence in consumer health
Western Europe accounts for one third of GSK consumer health sales
In North America and globally, US is GSK’s most lucrative market
Eastern Europe: GSK fastest growing market thanks to Novartis deal
Latin America remains underexploited
Brand Strategy
GSK leading consumer health brands
Top OTC GSK brands: After Novartis deal and Flonase switch
Panadol has plenty of room to grow
With Voltaren under GSK leadership, analgesic expansion continues
Flonase Rx-to-OTC switch boosts CCA sales in the US
Tums leads in the US, leaving other brands for the rest of the world
Operations
Development and innovation
Conclusion
GSK: Opportunities and challenges
Appendix
Data parameters and report definitions
Related Consumer Health content available in Passport
Why buy this report?
Gain competitive intelligence about market leaders. Track key industry trends, opportunities and threats. Inform your marketing, brand, strategy and market development, sales and supply functions.
Want to find out more about this report?
Request more informationComplete Catalogue
Company Reports
- Amway Corp in Consumer Health | Jun 2019
- Bayer AG (Merck & Co) in Consumer Health | Nov 2014
- Bayer AG in Consumer Health | Apr 2017
- Bayer in Consumer Health | Nov 2019
- Beiersdorf AG in OTC Healthcare | Aug 2009
- Boehringer Ingelheim GmbH in Consumer Health | May 2015
- Bristol-Myers Squibb Co in Consumer Health | Feb 2013
- General Nutrition Centers in Consumer Health | Nov 2018
- General Nutrition Centers Inc in Consumer Health | Mar 2013
- Glaxosmithkline Plc and Novartis AG in Consumer Health: Prospects for Their New Joint Venture | Sep 2014
- GlaxosmithklinePlc in Consumer Health | Sep 2019
- Herbalife Ltd in Consumer Health | Dec 2016
- Herbalife Nutrition Ltd | Jan 2019
- Herbalife Nutrition Ltd in Consumer Health | Mar 2020
- Johnson & Johnson in Consumer Health | Jul 2018
- Johnson & Johnson in Consumer Health | Nov 2019
- Johnson & Johnson Inc in Consumer Health | Jul 2015
- Merck & Co Inc in Consumer Health | Jul 2013
- Merck KGaA in Consumer Health | May 2012
- NBTY Inc in Consumer Health | Sep 2013
- Novartis AG in Consumer Health | Sep 2013
- Nu Skin Enterprises Inc in Consumer Health | Aug 2011
- Otsuka Pharmaceutical Co Ltd in Consumer Health | Aug 2010
- Pfizer Inc in Consumer Health | Nov 2017
- Procter & Gamble Co, The (P&G) in Consumer Health | Jan 2020
- Procter & Gamble Co, The in Consumer Health | Oct 2015
- Reckitt Benckiser in Consumer Health | Mar 2020
- Reckitt Benckiser Plc (RB) in Consumer Health | Jul 2018
- Sanofi in Consumer Health | Oct 2019
- Sanofi-Aventis in Consumer Health | Sep 2011
- Taisho Pharmaceutical Co Ltd in Consumer Health | Sep 2011
- Takeda Pharmaceutical Co Ltd in Consumer Health | Apr 2013
Complete Catalogue
Company Reports
- Amway Corp in Consumer Health | Jun 2019
- Bayer AG (Merck & Co) in Consumer Health | Nov 2014
- Bayer AG in Consumer Health | Apr 2017
- Bayer in Consumer Health | Nov 2019
- Beiersdorf AG in OTC Healthcare | Aug 2009
- Boehringer Ingelheim GmbH in Consumer Health | May 2015
- Bristol-Myers Squibb Co in Consumer Health | Feb 2013
- General Nutrition Centers in Consumer Health | Nov 2018
- General Nutrition Centers Inc in Consumer Health | Mar 2013
- Glaxosmithkline Plc and Novartis AG in Consumer Health: Prospects for Their New Joint Venture | Sep 2014
- GlaxosmithklinePlc in Consumer Health | Sep 2019
- Herbalife Ltd in Consumer Health | Dec 2016
- Herbalife Nutrition Ltd | Jan 2019
- Herbalife Nutrition Ltd in Consumer Health | Mar 2020
- Johnson & Johnson in Consumer Health | Jul 2018
- Johnson & Johnson in Consumer Health | Nov 2019
- Johnson & Johnson Inc in Consumer Health | Jul 2015
- Merck & Co Inc in Consumer Health | Jul 2013
- Merck KGaA in Consumer Health | May 2012
- NBTY Inc in Consumer Health | Sep 2013
- Novartis AG in Consumer Health | Sep 2013
- Nu Skin Enterprises Inc in Consumer Health | Aug 2011
- Otsuka Pharmaceutical Co Ltd in Consumer Health | Aug 2010
- Pfizer Inc in Consumer Health | Nov 2017
- Procter & Gamble Co, The (P&G) in Consumer Health | Jan 2020
- Procter & Gamble Co, The in Consumer Health | Oct 2015
- Reckitt Benckiser in Consumer Health | Mar 2020
- Reckitt Benckiser Plc (RB) in Consumer Health | Jul 2018
- Sanofi in Consumer Health | Oct 2019
- Sanofi-Aventis in Consumer Health | Sep 2011
- Taisho Pharmaceutical Co Ltd in Consumer Health | Sep 2011
- Takeda Pharmaceutical Co Ltd in Consumer Health | Apr 2013